SECOND RESTATED COLLABORATION AGREEMENTCollaboration Agreement • March 12th, 2010 • Celldex Therapeutics, Inc. • In vitro & in vivo diagnostic substances • Delaware
Contract Type FiledMarch 12th, 2010 Company Industry JurisdictionTHIS SECOND RESTATED COLLABORATION AGREEMENT (this “Agreement”), dated as of April 12, 2004, the “Revision Date”, is made between ABGENIX, INC., a Delaware corporation (“ABX”), having a place of business at 7601 Dumbarton Circle, Fremont, California 94555, and CURAGEN CORPORATION, a Delaware corporation (“CuraGen”), having a place of business at 555 Long Wharf Drive, New Haven, Connecticut 06511, with respect to the following facts:
SECOND RESTATED COLLABORATION AGREEMENTCollaboration Agreement • April 11th, 2005 • Curagen Corp • Services-commercial physical & biological research • Delaware
Contract Type FiledApril 11th, 2005 Company Industry Jurisdiction
SECOND RESTATED COLLABORATION AGREEMENTCollaboration Agreement • August 6th, 2004 • Curagen Corp • Services-commercial physical & biological research • Delaware
Contract Type FiledAugust 6th, 2004 Company Industry JurisdictionTHIS SECOND RESTATED COLLABORATION AGREEMENT (this “Agreement”), dated as of April 12, 2004, the “Revision Date”, is made between ABGENIX, INC., a Delaware corporation (“ABX”), having a place of business at 7601 Dumbarton Circle, Fremont, California 94555, and CURAGEN CORPORATION, a Delaware corporation (“CuraGen”), having a place of business at 555 Long Wharf Drive, New Haven, Connecticut 06511, with respect to the following facts: